Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-26

Clinical Trial Update: Comparative PK PD Study in PAH Patients (Fox vs. I-Neb) [Phase 1, Phase 2]

View source ↗

Summary

A comparative PK/PD study in pulmonary arterial hypertension patients comparing Fox with I-Neb across Phase 1 and Phase 2 is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fox
  • I-Neb

Snippet

Sponsor: Bayer | Conditions: Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: COMPLETED